65
Views
1
CrossRef citations to date
0
Altmetric
Biomedical Science in Brief

Association of 32-bp deletion polymorphism and promoter methylation of PTEN and hepatitis C virus induced hepatocellular carcinoma

ORCID Icon, , , , , , , & show all
Pages 195-197 | Received 08 Apr 2019, Accepted 09 May 2019, Published online: 21 Jun 2019

References

  • Arafa M, Besheer T, El-Eraky AM, et al. Genetic variants of XRCC1 and risk of hepatocellular carcinoma in chronic hepatitis C patients. Br J Biomed Sci. 2019;76:64–69.
  • Laurent-Puig P, Zucman-Rossi J. Genetics of hepatocellular tumors. Oncogene. 2006;25:3778–3786.
  • Eskandari E, Dahmadeh T, Dahmadeh F, et al. Lack of relationship between PTEN 32-bp and TP53 16-bp Ins/Del polymorphisms and chronic hepatitis B virus infection. Virus disease. 2017;28:289–294.
  • Khalid A, Hussain T, Manzoor S, et al. PTEN: A potential prognostic marker in virus-induced hepatocellular carcinoma. Tumor Biol. 2017;71–10.
  • Hashemi M, Rezaei H, Eskandari-Nasab E, et al. Association of promoter methylation and 32-Bp deletion of the pten gene with susceptibility to metabolic syndrome. Mol Med Rep. 2013;7:342–346.
  • Bruix J, Sherman M. Management of hepatocellular carcinoma: an update. Hepatology. 2011;53:1020–1022.
  • Ding J, Gao Y, Liu R, et al. Association of PTEN polymorphisms with susceptibility to hepatocellular carcinoma in a Han Chinese population. DNA Cell Biol. 2011;30:229–234.
  • Li H, Liu F, Zhu H, et al. Association of PTEN gene polymorphisms with liver cancer risk. Int J Clin Exp Path. 2015;8:15198–15203.
  • Sze K, Wong K, Chu G, et al. Loss of phosphatase and tensin homolog enhances cell invasion and migration through AKT/Sp-1 transcription factor/matrix metalloproteinase 2 activation in hepatocellular carcinoma and has clinicopathologic significance. Hepatology. 2011;53:1558–1569.
  • Zhou J, Li X. Association of PTEN expression with liver function and inflammatory changes in patients with liver cancer after chemotherapy. Oncol Lett. 2018;16:6633–6637.
  • Zhang Y, Li RQ, Feng XD, et al. Down-regulation of PTEN by HCV core protein through activating nuclear factor-kappa B. Int J Clin Exp Path. 2014;7:7351–7359.
  • Peyrou M, Bourgoin L, Foti M. PTEN in liver diseases and cancer. World J Gastroenterol. 2010;16:4627–4633.
  • Mirmohammadsadegh A, Marini A, Nambiar S, et al. Epigenetic silencing of the PTEN gene in melanoma. Cancer Res. 2006;66:6546–6552.
  • Yu J, Ni M, Xu J, et al. Methylation profiling of twenty promoter CpG islands of genes which may contribute to hepatocellular carcinogenesis. BMC Cancer. 2002;2:29.
  • Wang L, Wang W, Zhang Y, et al. Epigenetic and genetic alterations of PTEN in hepatocellular carcinoma. Hepatol Res. 2007;37:389–396.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.